REAL Stock Overview
Engages in the development, production, and sale of enzyme-based hygiene solutions and processes primarily in Belgium. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Realco SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.50 |
| 52 Week High | €18.80 |
| 52 Week Low | €12.30 |
| Beta | 0.078 |
| 11 Month Change | -13.79% |
| 3 Month Change | -16.67% |
| 1 Year Change | -33.51% |
| 33 Year Change | -13.79% |
| 5 Year Change | -47.92% |
| Change since IPO | 29.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| REAL | BE Chemicals | BE Market | |
|---|---|---|---|
| 7D | -5.3% | -2.4% | -1.6% |
| 1Y | -33.5% | -54.9% | 2.0% |
Return vs Industry: REAL exceeded the Belgian Chemicals industry which returned -54.9% over the past year.
Return vs Market: REAL underperformed the Belgian Market which returned 2% over the past year.
Price Volatility
| REAL volatility | |
|---|---|
| REAL Average Weekly Movement | 2.4% |
| Chemicals Industry Average Movement | 4.1% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in BE Market | 6.3% |
| 10% least volatile stocks in BE Market | 2.1% |
Stable Share Price: REAL has not had significant price volatility in the past 3 months compared to the Belgian market.
Volatility Over Time: REAL's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 48 | George Blackman | www.realco.be |
Realco SA engages in the development, production, and sale of enzyme-based hygiene solutions and processes primarily in Belgium. It serves food and beverage, food service, medical, and home hygiene sectors. Realco SA was founded in 1968 and is based in Louvain-La-Neuve, Belgium.
Realco SA Fundamentals Summary
| REAL fundamental statistics | |
|---|---|
| Market cap | €8.50m |
| Earnings (TTM) | €259.37k |
| Revenue (TTM) | €11.68m |
31.0x
P/E Ratio0.7x
P/S RatioIs REAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REAL income statement (TTM) | |
|---|---|
| Revenue | €11.68m |
| Cost of Revenue | €7.45m |
| Gross Profit | €4.23m |
| Other Expenses | €3.97m |
| Earnings | €259.37k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.40 |
| Gross Margin | 36.24% |
| Net Profit Margin | 2.22% |
| Debt/Equity Ratio | 65.1% |
How did REAL perform over the long term?
See historical performance and comparison